Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Beezaasan Exp.
Quarter-by-quarter operating performance
Financials of Beezaasan Exp.
Annual income statement trend
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales + | 36 | 58 | 142 | 229 | 187 | 215 | 212 |
| Expenses + | 34 | 55 | 135 | 220 | 175 | 194 | 193 |
| Operating Profit | 2 | 3 | 7 | 9 | 12 | 21 | 18 |
| OPM % | 5% | 5% | 5% | 4% | 6% | 10% | 9% |
| Other Income + | 0 | 0 | 0 | 0 | 0 | 1 | 2 |
| Interest | 1 | 1 | 2 | 3 | 3 | 3 | 1 |
| Depreciation | 0 | 1 | 1 | 2 | 2 | 2 | 3 |
| Profit before tax | 0 | 2 | 4 | 4 | 7 | 16 | 16 |
| Tax % | 94% | 34% | 24% | 26% | 24% | 25% | 24% |
| Net Profit + | 0 | 1 | 3 | 3 | 5 | 12 | 12 |
| EPS in Rs | 0.02 | 1.75 | 4.36 | 4.20 | 5.36 | 9.52 | 7.79 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Beezaasan Exp.
Capital structure and asset base
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 6 | 7 | 7 | 10 | 13 | 15 |
| Reserves | -0 | 1 | 5 | 7 | 14 | 83 | 138 |
| Borrowings + | 13 | 18 | 24 | 44 | 34 | 22 | 35 |
| Other Liabilities + | 4 | 3 | 7 | 4 | 9 | 9 | 12 |
| Total Liabilities | 21 | 28 | 43 | 63 | 67 | 127 | 200 |
| Fixed Assets + | 8 | 16 | 19 | 24 | 30 | 34 | 47 |
| CWIP | 5 | 0 | 0 | 3 | 2 | 12 | 3 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 53 |
| Other Assets + | 8 | 13 | 24 | 35 | 36 | 82 | 97 |
| Total Assets | 21 | 28 | 43 | 63 | 67 | 127 | 200 |
Financials of Beezaasan Exp.
Operating, investing and financing cash movement
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 2 | -0 | -0 | 17 | 7 | 4 | |
| Cash from Investing Activity + | -5 | -3 | -5 | -12 | -6 | -35 | |
| Cash from Financing Activity + | 4 | 3 | 6 | 1 | -6 | 49 | |
| Net Cash Flow | -0 | 0 | 0 | 7 | -4 | 18 | |
| Free Cash Flow | -3 | -10 | -5 | 11 | 2 | -13 | |
| CFO/OP | 97% | -4% | -2% | 203% | 67% | 25% |
Financials of Beezaasan Exp.
Working capital efficiency and return ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 51 | 36 | 28 | 17 | 13 | 11 | 22 |
| Inventory Days | 31 | 49 | 34 | 25 | 47 | 52 | 80 |
| Days Payable | 43 | 19 | 13 | 3 | 3 | 0 | 7 |
| Cash Conversion Cycle | 39 | 66 | 49 | 40 | 57 | 63 | 95 |
| Working Capital Days | -24 | -2 | 12 | -12 | -3 | 40 | 47 |
| ROCE % | 11% | 18% | 16% | 18% | 21% | 11% |
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…